136
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Predictors of Illness Severity in COVID-19 Cases in Saudi Arabia

ORCID Icon, ORCID Icon, , ORCID Icon, , , , , , , , ORCID Icon & show all
Pages 4097-4105 | Published online: 05 Oct 2021

References

  • Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa200101731978945
  • Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-732015507
  • Ji W, Wang W, Zhao X, Zai J, Li X. Cross-species transmission of the newly identified coronavirus 2019-nCoV. J Med Virol. 2020;92(4):433–440. doi:10.1002/jmv.2568231967321
  • Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221–236. doi:10.1080/22221751.2020.171990231987001
  • Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. doi:10.1016/S0140-6736(20)30154-931986261
  • Dong L, Li Z, Fung ICH. A call for consistency in the official naming of the disease caused by severe acute respiratory syndrome Coronavirus 2 in non-English languages. Disaster Med Public Health Prep. 2020;14:e25–e26.
  • Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Euro Surveill. 2020;25(5). doi:10.2807/1560-7917.ES.2020.25.5.2000062
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-531986264
  • Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843–851. doi:10.1111/apt.1573132222988
  • Song W, Li J, Zou N, Guan W, Pan J, Xu W. Clinical features of pediatric patients with coronavirus disease (COVID-19). J Clin Virol. 2020;127:104377. doi:10.1016/j.jcv.2020.10437732361323
  • Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094. doi:10.1136/bmj.m209432493739
  • Rauf A, Vijayan A, John ST, Krishnan R, Latheef A. Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 pandemic. Indian J Pediatr. 2020;87(9):745–747. doi:10.1007/s12098-020-03357-132462354
  • Yang H, Sun G, Tang F, et al. Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019. J Infect. 2020;81(1):e40–e44. doi:10.1016/j.jinf.2020.04.00332294503
  • World Health Organization. Coronavirus disease (COVID-19); 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200921-weekly-epi-update-6.pdf?sfvrsn=d9cf9496_4. Accessed October 1, 2021.
  • Phan T. Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol. 2020;81:104260. doi:10.1016/j.meegid.2020.10426032092483
  • Biswas SK, Mudi SR. Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19. Med Hypotheses. 2020;143:109877. doi:10.1016/j.mehy.2020.10987732464496
  • Hoehl S, Ciesek S. The virology of SARS-CoV-2. Internist. 2020;61(8):789–792. doi:10.1007/s00108-020-00853-6
  • Ministry of Health. Saudi MoH protocol for patients suspected of/confirmed with COVID-19 version 2.1; 2020. Available from: https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/MOH-therapeutic-protocol-for-COVID-19.pdf. Accessed October 1, 2021.
  • de Lusignan S, Dorward J, Correa A, et al. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect Dis. 2020;20(9):1034–1042. doi:10.1016/S1473-3099(20)30371-632422204
  • Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020;20(7):773. doi:10.1016/S1473-3099(20)30195-X
  • Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020;173(5):362–367. doi:10.7326/M20-301232491919
  • World Health Organization. COVID-19 pandemic planning scenarios; 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html. Accessed October 1, 2021.
  • CDC. Estimating mortality from COVID-19; 2020. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci-Brief-Mortality-2020.1. Accessed October 1, 2021.
  • Weinberger DM, Chen J, Cohen T, et al. Estimation of excess deaths associated with the COVID-19 pandemic in the United States, March to May 2020. JAMA Intern Med. 2020;180(10):1336. doi:10.1001/jamainternmed.2020.339132609310
  • Kragholm K, Andersen MP, Gerds TA, et al. Association between male sex and outcomes of Coronavirus disease 2019 (Covid-19) - a Danish nationwide, register-based study. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa924
  • Suleyman G, Fadel RA, Malette KM, et al. Clinical characteristics and morbidity associated with Coronavirus disease 2019 in a series of patients in metropolitan detroit. JAMA Netw Open. 2020;3(6):e2012270. doi:10.1001/jamanetworkopen.2020.1227032543702
  • Bonanad C, Garcia-Blas S, Tarazona-Santabalbina F, et al. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020;21(7):915–918. doi:10.1016/j.jamda.2020.05.04532674819
  • Rimmer A. Covid-19: two thirds of healthcare workers who have died were from ethnic minorities. BMJ. 2020;369:m1621. doi:10.1136/bmj.m162132327412
  • Hughes MM, Groenewold MR, Lessem SE, et al. Update: characteristics of health care personnel with COVID-19 - United States, February 12–July 16, 2020. Morb Mortal Wkly Rep. 2020;69(38):1364–1368. doi:10.15585/mmwr.mm6938a3
  • Kambhampati AK, O’Halloran AC, Whitaker M, et al. COVID-19-associated hospitalizations among health care personnel - COVID-NET, 13 States, March 1–May 31, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(43):1576–1583. doi:10.15585/mmwr.mm6943e333119554
  • Tai DBG, Shah A, Doubeni CA, Sia IG, Wieland ML. The disproportionate impact of COVID-19 on racial and ethnic minorities in the United States. Clin Infect Dis. 2021;72(4):703–706. doi:10.1093/cid/ciaa81532562416
  • Karaca-Mandic P, Georgiou A, Sen S. Assessment of COVID-19 hospitalizations by race/ethnicity in 12 states. JAMA Intern Med. 2021;181(1):131–134. doi:10.1001/jamainternmed.2020.385732804192
  • 2018 American Community Survey -yS. Hispanic Americans in healthcare and in essential roles new American economy; 2020. Available from: https://research.newamericaneconomy.org/report/hispanic-americans-in-healthcare-and-in-essential-roles/. Accessed October 1, 2021.
  • Chowkwanyun M, Reed AL. Racial health disparities and Covid-19 - caution and context. N Engl J Med. 2020;383(3):201–203. doi:10.1056/NEJMp201291032374952
  • Webb Hooper M, Napoles AM, Perez-Stable EJ. COVID-19 and racial/ethnic disparities. JAMA. 2020;323(24):2466–2467. doi:10.1001/jama.2020.859832391864
  • Deidda S, Tora L, Firinu D, et al. Gastrointestinal Coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention and management. Expert Rev Gastroenterol Hepatol. 2021;15:41–50.32955375
  • Christophers B, Marin BG, Oliva R, Powell WT, Savage TJ, Michelow IC. Trends in clinical presentation of children with COVID-19: a systematic review of individual participant data. Pediatr Res. 2020. doi:10.1038/s41390-020-01161-3
  • Mantovani A, Byrne CD, Zheng MH, Targher G. Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies. Nutr Metab Cardiovasc Dis. 2020;30(8):1236–1248. doi:10.1016/j.numecd.2020.05.01432571616
  • Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2021;2(1):e13–e22. doi:10.1016/S2666-5247(20)30172-533521734
  • Aranha C, Patel V, Bhor V, Gogoi D. Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: an approach to reduce the isolation period for COVID-19 patients. J Med Virol. 2021. doi:10.1002/jmv.27206
  • Platten M, Hoffmann D, Grosser R, et al. SARS-CoV-2, CT-values, and infectivity—conclusions to be drawn from side observations. Viruses. 2021;13(8):1459. doi:10.3390/v1308145934452325
  • Shah S, Singhal T, Davar N, Thakkar P. No correlation between Ct values and severity of disease or mortality in patients with COVID 19 disease. Indian J Med Microbiol. 2021;39(1):116–117. doi:10.1016/j.ijmmb.2020.10.02133610241
  • Bullard J, Dust K, Funk D, et al. Predicting infectious SARS-CoV-2 from diagnostic samples. Clin Infect Dis. 2020;71(10):2663–2666. doi:10.1093/cid/ciaa63832442256
  • Liu WD, Chang SY, Wang JT, et al. Prolonged virus shedding even after seroconversion in a patient with COVID-19. J Infect. 2020;81(2):318–356.
  • Perera R, Tso E, Tsang OTY, et al. SARS-CoV-2 virus culture and subgenomic RNA for respiratory specimens from patients with mild Coronavirus disease. Emerg Infect Dis. 2020;26(11):2701–2704. doi:10.3201/eid2611.20321932749957
  • Wolfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465–469. doi:10.1038/s41586-020-2196-x32235945
  • Cheung KS, Hung IFN, Chan PPY, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159(1):81–95. doi:10.1053/j.gastro.2020.03.06532251668
  • Zheng S, Fan J, Yu F, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January–March 2020: retrospective cohort study. BMJ. 2020;369:m1443. doi:10.1136/bmj.m144332317267
  • Jeong HW, Kim SM, Kim HS, et al. Viable SARS-CoV-2 in various specimens from COVID-19 patients. Clin Microbiol Infect. 2020;26(11):1520–1524. doi:10.1016/j.cmi.2020.07.02032711057